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Perioperative cardiac complications remain an
important source of morbidity and mortality among
patients undergoing vascular surgery.1-4 In the last two
decades, numerous studies have attempted to identify
patients at risk for cardiac complications after noncar-
diac surgery by using clinical markers or specialized
testing.5-10 Usually, strategies for preoperative cardiac
evaluation have attempted to reach a complete under-
standing of the patient’s cardiovascular status.
However, the assumption that more information leads
to improved care has been shown to be false.11-13 On
the other hand, the current era of cost containment
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Purpose: We assessed whether the American College of Cardiology/American Heart
Association (ACC/AHA) task force guidelines for perioperative cardiac evaluation could
reliably stratify cardiac risk before aortic surgery.
Methods: We retrospectively applied the guidelines to a closed database, set up prospective-
ly. The setting was a referral center in an institutional practice with hospitalized patients.
The closed database included 133 patients who had a routine cardiac examination, which
comprised an estimation of functional capacity and noninvasive testing, before aortic
surgery. This cardiac evaluation led to the proposal of coronarography in 23 patients and
to treating an underlying coronary artery disease in 21 patients (including three myocar-
dial revascularizations). One patient died after myocardial revascularization, and two
patients died of cardiac causes after aortic surgery. The algorithm of the ACC/AHA
guidelines was applied independently by two investigators to each patient’s file that was
included in the existing database. The main outcome measure was a comparison between
cardiac risk stratification with the ACC/AHA guidelines and the results of the routine
cardiac evaluation.
Results: The ACC/AHA guidelines were successfully applied to all 133 files by the two
investigators. After applying the algorithm, 73 patients were stratified as low cardiac
risk, and 60 patients were stratified as high risk. The 21 patients who had undergone a
preoperative coronary artery disease optimization were stratified as high risk by means
of the ACC/AHA guidelines. The patients who died from cardiac causes were stratified
as high risk by means of the ACC/AHA guidelines, whereas none of the patients strat-
ified as low risk died during hospitalization.
Conclusion: The ACC/AHA guidelines were effective in stratifying cardiac risk by using
clinical predictors and an estimate of the physical capacity of the patient. Their use may
allow a reduction in unnecessary noninvasive testing in patients stratified as being at low
risk, while permitting the selection of all patients likely to benefit from preoperative
coronary artery disease optimization. (J Vasc Surg 2000;31:971-9.)
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dictates that any potential for modifying perioperative
management should be determined before additional
tests are planned.12 At present, randomized, con-
trolled clinical trials to define the optimal evaluation
strategy are still lacking. The demand for guidance in
perioperative evaluation has recently prompted the
American College of Cardiology/American Heart
Association (ACC/AHA) task force to propose guide-
lines for the cardiovascular evaluation of patients
undergoing noncardiac surgery.14 These guidelines,
based on a step-wise Bayesian strategy, are intended to
identify which patients are candidates for cardiac test-
ing, for specific management of an associated car-
diopathy, or both. The decision-making process inte-
grates clinical markers, earlier coronary evaluation,
functional capacity, and the type of surgery involved.
These guidelines are based on an analysis of the
English literature of the last 20 years and on the expert
opinions of committee members. If successful, the
strategy should separate patients into various cate-
gories, allowing their treatment to be tailored to their
needs. However, the application of this algorithm in
clinical practice has not yet been evaluated.
The aim of this study was to determine whether
the ACC/AHA guidelines could reliably stratify
patients who might benefit from coronary artery dis-
ease (CAD) optimization before aortic surgery. We
applied the ACC/AHA guidelines to a series of
patients who had previously undergone routine car-
diac examination, including noninvasive testing.
PATIENTS AND METHODS
Database. With institutional approval, the files of
138 consecutive patients scheduled for elective aortic
reconstruction at our institution from February 1993
to December 1994 were prospectively included in a
database. All patients gave informed consent to
undergo preoperative cardiac examination and to
have their medical data stored for subsequent analysis.
Four files were deleted from analysis because the car-
diac evaluation was not complete. The file of an 89-
year-old patient was also deleted. The demographic
characteristics, comorbid conditions, American
Society of Anesthesiologists physical status, Goldman
cardiac risk index, 5 functional status, and earlier treat-
ments of the 133 patients (122 men, 11 women) are
shown in Table I. The indication for the aortic graft
procedure (straight tube or bifurcated graft) was aor-
tic aneurysm in 52 patients and aortoiliac occlusive
disease in 81 patients. Surgery was transperitoneal in
120 patients (90%).
Functional status was classified as “normal” or
“poor,” according to the capacity of the patient
(determined by means of history) to climb a flight of
stairs without physical discomfort. This activity
approximately corresponds to an oxygen demand of 4
metabolic equivalents (MET).15 If functional capacity
could not be reliably estimated because the patient
had very low physical activity, it was classified as poor.
Ten patients had undergone myocardial revascu-
larization in the previous 5 years (percutaneous
transluminal coronary angioplasty [PTCA] in six
patients; coronary artery bypass grafting [CABG] in
three patients; PTCA 1 year after a CABG in one
patient). A coronary examination had been per-
formed in the last 2 years in six patients. One of
these patients was found to have no evidence of
CAD, and the coronary risk of the remaining five
patients was considered to have been adequately
assessed by the attending cardiologist. The clinical
status of these 16 patients was stable without recur-
rent symptoms, and therefore, no additional preop-
erative testing was undertaken.
Noninvasive cardiac testing was planned in 117
patients. It comprised dipyridamole thallium imag-
ing (DTI) and stress dobutamine echocardiography
(SDE), both of which were performed according to
standardized protocols.11,16 Two patients treated
with theophylline did not undergo DTI. Twenty-
one patients had positive results on their DTI,
defined quantitatively as a reversible perfusion defect
in two or more coronary artery territories. SDE was
not performed in one patient with a permanent car-
diac stimulator, nor was it performed in three
patients with significant ventricular arrhythmias.
Positive results on an SDE were defined as an
increase in regional wall motion score in 1 or more
segments from rest to stress, an ST segment depres-
sion more than 2 mm measured 80 ms after the J
point, ST segment elevation, or significant chest
pain. The results of the SDE were found to be pos-
itive in 15 patients. Twenty-three patients had
abnormal results on noninvasive testing, and both
the DTI and SDE were positive in 13 cases.
The indications for coronary angiography were a
Canadian Cardiovascular Society class III or IV CAD
and/or a positive DTI and/or SDE. Therefore, a
coronary angiography was planned for the 23
patients who had abnormal results on noninvasive
testing. Angiography could not be performed in one
patient with a positive DTI and SDE. Significant
stenoses on one, two, and three coronary arteries
were found in six, 12, and three patients, respective-
ly. A false positive result for DTI was considered in
one patient who had a positive DTI result but nor-
mal SDE and coronarography results. 
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A specific CAD optimization was finally pro-
posed for 21 patients (16%) before surgery, includ-
ing medical treatment with oral beta blockers or cal-
cium channel blockers and CABG for three patients.
The demographic characteristics of the patients who
had or did not have a preoperative CAD-specific
optimization are listed in Table I. 
One patient died of a massive gastric hemorrhage
10 days after CABG. Aortic surgery was, therefore,
performed on 132 patients. Patients were admitted to
a surgical intensive care unit for at least 3 days after
surgery. On postoperative days 1 and 3, cardiac isoen-
zymes were measured and a 12-lead electrocardio-
gram (ECG) was recorded. Six postoperative deaths
occurred during hospitalization (4.6%). Death was
related primarily to myocardial infarction in two
patients, to massive hemorrhage in one patient, and to
sepsis and multiple organ failure in three patients.
Application of the American College of
Cardiology/American Heart Association guide-
lines. The step-wise approach of the ACC/AHA
guidelines was applied to all files in the database. The
use of the algorithm required an appreciation of the
patient’s clinical status, functional capacity, and the
type of surgery to be undertaken. The algorithm
(adapted, because only aortic surgery was considered
in our study) is shown in Fig 1. In brief, step 1 deter-
mined the urgency of surgery. Step 2 affected patients
who had undergone coronary artery revascularization
in the previous 5 years. If their clinical status remained
stable without recurrent symptoms, further cardiac
testing was not required. In step 3, any coronary eval-
uation performed during the previous 2 years was
analyzed. When coronary risk had been adequately
assessed and the findings were favorable, no addition-
al cardiac testing was required. In steps 4 and after,
the consultant determined: (1) whether the patient
had major, intermediate, or minor clinical predictors
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Table I. Demographic data of the 133 patients included in the database
Preoperative CAD treatment
All patients
Number (%) Yes (n = 21) No ( n = 112) (n = 133)
Age (years) 63.7 ± 9.2 62.3 ± 9.5 62.6 ± 9.4
Smoking habit 20 (95.2%) 108 (96.4%) 128 (96.2%)
PMH
CAD 6 (28.6%) 30 (26.8%) 36 (27.1%)
Angina 3 (14.3%) 20 (17.9%) 23 (17.3%)
MI 4 (19.0%) 19 (17.0%) 23 (17.3%)
CABG (total/within 5 years) 0/0 6/4 (5.3%/3.5%) 6/4 (4.5%/3.0%)
PTCA (total/within 5 years) 0/0 7/7 (6.2%/6.2%) 7/7 (5.3%/5.3%)
Congestive heart failure 3 (14.3%) 2 (1.8%)* 5 (3.8%)
Hypertension 8 (38.1%) 44 (39.3%) 52 (39.1%)
Diabetes mellitus 1 (4.8%) 9 (8.0%) 10 (7.5%)
Physical capacity
Normal or moderate 3 (14%) 75 (66%)† 78 (58%)
Poor or unknown 18 (86%) 37 (33%)† 55 (41%)
ASA physical status
Class I or II 18 (86%) 106 (95%)† 124 (93%)
Class III 3 (14%) 6 (5%) 9 (7%)
Goldman risk index
Class I or II 21 (100%) 108 (96.4%) 102 (76.7%)
Class III 0 4 (3.6%) 4 (3.0%)
Current treatment
ACE inhibitors 4 (19.0%) 23 (20.5%) 27 (20.3%)
Beta blockers 5 (23.8%) 21 (18.7%) 26 (19.5%)
CC blockers 6 (28.6%) 37 (33.0%) 43 (32.3%)
Nitrates 1 (4.6%) 17 (15.2%) 18 (13.5%)
The first column applies to patients who had a preoperative specific treatment of coronary artery disease before aortic surgery; the sec-
ond column applies to patients who had undergone aortic surgery without alteration in preoperative treatment. Physical capacity refers
to the capacity of the patient to climb a flight of stairs without physical discomfort. The Goldman cardiac risk index was determined
according to Goldman et al.5
*P <.05.
†P <.001 versus preoperative CAD treatment.
CAD, Coronary artery disease; PMH, past medical history; MI, myocardial infarction; CABG, coronary artery bypass grafting; PTCA,
percutaneous transluminal coronary angioplasty; ASA, American Society of Anesthesiologists; ACE, angiotensin conversion enzyme; CC
blockers, calcium channel blockers.
of cardiac risk; (2) the functional capacity of the
patient; and (3) the surgery-specific risk. 
Major clinical predictors were: unstable coronary
syndromes, including recent (less than 1 month ear-
lier) myocardial infarction; decompensated conges-
tive heart failure; hemodynamically significant
arrhythmias; and severe valve disease. Intermediate
clinical predictors were angina pectoris, earlier
myocardial infarction, compensated or earlier con-
gestive heart failure, and diabetes mellitus. Minor
clinical predictors included advanced age, abnormal
ECG results, a rhythm other than the sinus, low
functional status, a history of stroke, and uncon-
trolled systemic hypertension. 
Functional status was classified as “good” or “mod-
erate” when the patient could reach a metabolic
demand of at least 4 MET and “poor” when exercise
capacity was below 4 MET or could not be reliably eval-
uated. Aortic surgery was a high surgery-specific risk. 
Application of the algorithm allowed patients to
be divided into low and high cardiac risk: low-risk
patients were able to undergo surgery without fur-
ther investigation, and high-risk patients were con-
sidered for additional noninvasive cardiac testing
(Fig 1). The ACC/AHA guidelines were applied
independently to each patient’s file by two anesthe-
siologists. These investigators were aware only of
those data required to apply the strategy: past med-
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Fig 1. Prevalence of estimated cardiac risk and the indications for further coronary angiogra-
phy, noninvasive investigation, or no investigation resulting from the use of the American
College of Cardiology/American Heart Association guidelines. The algorithm has been adapt-
ed, because only one type of surgery was considered in this study.
ical history, physical examination results and func-
tional capacity, indication for surgery, and resting
ECG. They were blinded to the results of SDE and
DTI, coronarography, the final decision on CAD
management, and the patient’s outcome. Any prob-
lems met by the investigators in applying the
ACC/AHA guidelines were recorded, and any dis-
agreements with the conclusions drawn by the inves-
tigators were analyzed separately.
The main end point for the study analysis was the
comparison between the cardiac risk stratification
with the ACC/AHA guidelines and the results of
the systematic evaluation of the patients.
Statistical analysis. Continuous variables are
expressed as means plus or minus SD. Categorical vari-
ables were analyzed by means of the Fisher exact test,
and continuous variables were analyzed by means of the
Student t test for unpaired data. Data were analyzed
with Statview 4.5 software (Abacus Concept, Calif). A
P value less than .05 was considered significant.
RESULTS
The ACC/AHA guidelines were successfully
applied to all 133 files stored in the database.
Independent application of the algorithm by the two
principal investigators gave identical results in all
133 cases.
The prevalence of estimated cardiac risk and the
indications for further noninvasive investigation
resulting from the use of the guidelines are shown in
Fig 1. The 16 patients who had undergone previous
myocardial revascularization, a recent coronary eval-
uation, or both were stratified as low-risk, because
they were in a stable clinical condition. Of the
remaining 117 patients, no patient had major clini-
cal predictors, 25 patients had intermediate clinical
predictors, and 92 patients had minor or no clinical
predictors (Fig 1). After the algorithm had been
applied, 57 more patients were stratified as low-risk
and were able to undergo surgery without further
investigation. Preoperative noninvasive testing was
considered in 60 patients, who were stratified as
being at high cardiac risk (Fig 1).
Preoperative data and the results of noninvasive
testing in patients stratified as low and high risk after
application of ACC/AHA guidelines are shown in
Table II.
One patient stratified as low risk was considered
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Table II. Clinical data, results of noninvasive testing, and cardiac-specific treatment of patients stratified as
being at low cardiac risk or at high cardiac risk by means of the American College of Cardiology/American
Heart Association guidelines
Cardiac risk stratification with ACC/AHA guidelines
Number (%) Low risk (n = 73) High risk (n = 60) P value
Age (years) 63 ± 9 62 ± 9 NS
PMH
Coronary artery disease 15 (20.5%) 21 (35.0%) NS
Angina pectoris 11 (15.1%) 12 (20.0%) NS
Myocardial infarction 9 (12.3%) 14 (23.3%) NS
CABG 4 (5.5%) 2 (3.3%) NS
PTCA 7 (9.6%) 0 .037
Congestive heart failure 1 (1.4%) 4 (6.7%) NS
Hypertension 29 (39.7%) 23 (38.3%) NS
Diabetes mellitus 3 (4.1%) 7 (11.7%) NS
Goldman risk index
Class I 63 (86.3%) 39 (65.0%) .011
Class II 8 (11.0%) 19 (31.7%) .010
Class III 2 (2.7%) 2 (3.3%) NS
Functional status
Normal or moderate 68 (93.2%) 10 (16.7%) < .0001
Poor or unknown 51 (6.8%) 50 (83.3%) < .0001
DTI (n/positive test) 55/1 (75%/1.4%) 60/20 (100%/33%) < .0001
SDE (n/positive test) 54/0 (74%/0%) 57/15 (78%/25%) < .0001
Coronarography (n/coronary stenosis) 1/0 (1.4%/0%) 21/21 (35%/35%) < .0001
Preoperative CAD optimization 0 21 (35%) < .0001
Myocardial revascularization (CABG) 0 3 (5%) NS
Goldman cardiac risk index was determined according to Goldman et al.5
ACC/AHA, American College of Cardiology/American Heart Association; PMH, past medical history; NS, not significant; CABG,
coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty; DTI, dipyridamole thallium imaging; SDE,
stress dobutamine echocardiography; CAD, coronary artery disease.
to have had false-positive results on the DTI,
because the results of both the SDE and coronarog-
raphy were normal. In the remaining 56 patients,
none of the DTI and SDE results were positive, and
all patients underwent surgery without further
investigation (Table II).
The results of noninvasive testing either were nor-
mal or revealed only minor abnormalities in 38 of the
60 patients (63%) stratified as high risk by the
ACC/AHA guidelines (Table II). The remaining 22
patients (37%) had either a positive DTI (20 patients)
and/or a positive SDE (15 patients), and they were
considered for coronary angiography. In the sub-
group of patients stratified as high cardiac risk by
means of the ACC/AHA guidelines, age, comorbid
conditions, or physical capacity was not significantly
different between patients with negative and positive
noninvasive testing results (results not shown). 
The 21 patients who had undergone a specific pre-
operative CAD treatment (including the three patients
who underwent myocardial revascularizations) were
stratified as high risk by means of the ACC/AHA
guidelines. None of the patients stratified as low risk by
means of the ACC/AHA guidelines died during hos-
pitalization after aortic surgery. The three patients who
died of cardiac causes had been stratified as high risk
by means of the ACC/AHA guidelines.
DISCUSSION
The main finding of this study was that the
ACC/AHA guidelines were an effective means of
stratifying cardiac risk before aortic surgery. By using
the clinical predictors of the algorithm, we found
that 45% of the patients were stratified as being at
high risk and were, therefore, considered for nonin-
vasive testing. Among those patients considered for
noninvasive testing, 37% had significant CAD. All
the patients who had CAD severe enough to require
a preoperative treatment (16% of all patients) were
correctly stratified as high risk by means of the
ACC/AHA guidelines. 
This study is the first attempt to test the applica-
tion of the ACC/AHA guidelines for patients
undergoing aortic surgery. We used an existing data-
base of 133 patients who had undergone a routine
preoperative cardiac examination, including an esti-
mation of functional capacity and noninvasive test-
ing. This database was considered adequate, because
the clinical parameters necessary for applying the
algorithm, including estimates of physical capacity,
had been prospectively recorded for each patient.
The preoperative cardiac evaluation of patients
undergoing aortic surgery often presents a special chal-
lenge to surgical teams. The limitations of cardiac risk
scores and the physical impairment imposed by vascu-
lar disease have resulted in an excessive use of preoper-
ative testing.7,9,10,17 Strategies for preoperative cardiac
evaluation that attempted to offer a complete under-
standing of a patient’s cardiovascular status were
reported to have a low cost/effectiveness ratio.11,12
In the preoperative period, risk stratification is
used as a means of selecting patients who may bene-
fit from a specific cardiac treatment, while avoiding
unnecessary, expensive, and potentially dangerous
cardiac evaluation.12,18,19 To be applicable in clinical
practice, this stratification must be based on parame-
ters routinely available during the preoperative eval-
uation, and not on specialized testing. The algo-
rithm of the ACC/AHA task force is based on the
assumption that defining clinical predictors, estimat-
ing the functional capacity of the patient, and noting
the surgery-specific risk will adequately identify
those patients for whom further cardiac evaluation
may be useful. The surgery-specific cardiac risk strat-
ification is related to the degree of hemodynamic
cardiac stress associated with operative technique
and to the likelihood of underlying heart disease
associated with the type of surgery.2,20,21 Thus, aor-
tic and infrainguinal bypass grafting surgery have
been designated as high-risk surgeries by the
ACC/AHA task force. Anticipated prolonged
surgery involving the abdomen, thorax, head, and
neck that is associated with large fluid shift or blood
loss has been stratified as high risk, whereas inter-
mediate surgical risks include carotid endarterecto-
my and urologic, orthopedic, and uncomplicated
abdomen, head, neck, and thoracic procedures.
Compared with a strategy based on the systematic
use of noninvasive testing before aortic surgery, the
stratification laid down in the guidelines may prove
useful, because only 45% of the patients were con-
sidered for noninvasive testing. Of these patients,
37% (ie, 16% of all patients) were found to be at high
risk by means of noninvasive test results. This per-
centage of patients with positive test results is lower
than that previously reported in most studies involv-
ing patients undergoing aortic surgery.11,20,22,23
This discrepancy may be related to a difference in
the definition of a positive test result or in certain
demographic characteristics of the population stud-
ied. Both the mean age of the patients and the
prevalence of diabetes mellitus are relatively low in
our series, as compared with previous reports.13,24
Whether this lower disease incidence may have
altered the clinical profiling of patients deserves fur-
ther investigation.
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Further improvement in patient stratification
should focus on the subgroup of patients who were
considered to be at high risk according to clinical
predictors, but whose noninvasive testing results
showed no or only minor abnormalities. However,
such an improvement may be difficult to achieve,
because we failed to identify a clinical parameter that
might help to differentiate these patients from those
patients with high-risk noninvasive testing. This may
mean that the limits on the selection of patients car-
ried out with clinical parameters have been reached. 
On the other hand, the clinical approach used in
the guidelines demonstrated excellent stratification
of patients at low risk. None of the patients stratified
as being at low risk according to clinical predictors
had positive results on noninvasive testing. 
Physical capacity is a major determinant of the
decision algorithm. Functional status can be estimat-
ed from various activity scores or from treadmill
exercise protocols.25 However, to be effective in
clinical practice, the estimation must be rapid and
based on an analysis of daily living activity parame-
ters. In our study, functional activity was assessed by
means of the capacity of the patient to climb a flight
of stairs without discomfort. This corresponds to a
metabolic demand of approximately 4 MET.15 Few
reports have studied the real importance of physical
status on cardiac risk.26 Patients who cannot reach
an oxygen demand of 5 MET have been shown to
have an increased risk of perioperative complica-
tions. Flechter et al27 reported that patients with a
moderate or excellent functional status were at lower
risk for perioperative complications after high-risk
vascular surgery. Recently, Bartel et al4 reported that
an estimate of patients’ functional status could help
in identifying those patients who were at high risk
for perioperative cardiac complications.
In our study, a coronarography was performed
when abnormalities suggesting severe myocardial
ischemia during myocardial stress were revealed by
means of at least one of the two noninvasive tests.
DTI and SDE have strengths and limitations that
have been discussed in other studies, and the deci-
sion to proceed with coronary angiography and
myocardial revascularization still varies from one
team to another.9,11,22,28-32 It has been suggested by
means of analyses from formal decision models that
there is no net risk reduction if CABG is done before
noncardiac surgery, but several large cohort studies
have suggested that in patients who survive CABG,
the risk of subsequent noncardiac surgery is low.33-35
In our experience, myocardial revascularization was
considered the best therapeutic option in only three
patients, but one of these patients died after the
myocardial revascularization. This case underlines
the difficulty of trying to improve outcome with
specific preoperative management.
Links to outcome measurements in clinical stud-
ies are necessary to validate a preoperative strategy.
Our study showed that no cardiac death occurred in
patients assigned to the low-risk group during their
hospital stays, whereas the three patients who died
of cardiac causes were classified as high risk. This is
in accord with the results of Bartels et al,4 who
demonstrated a good clinical outcome by using car-
diac-risk stratification for high-risk vascular surgery,
according to a protocol based on the same principle
as that of the ACC/AHA guidelines.
The development of clinical practice guidelines
has emerged as a response to the variation in practice
among physicians to promote better outcomes and
to slow the rising cost of health care.36,37 The
demand for guidance in the perioperative evaluation
probably reflects an increasing use of surgical proce-
dures in older patients, the availability of multiple
technologies with which to evaluate risk, and the
confusion surrounding the goals of perioperative
assessment. Numerous attempts to define a strategy
for preoperative cardiac evaluation have been made
in the last few years, reflecting the lack of consensus
among the different teams.4,12,19,38-43
This diversity may also reflect the challenge to
physicians of trying to implement guidelines.44
Several authors have shown that no single imple-
mentation strategy is appropriate; each strategy is
influenced by the person using the guidelines, by the
incentive system, and by the guidelines’ content.44
Real-time implementation strategies that seek to
intervene at the moment at which the physician is
making key decisions would probably be useful.45
The algorithm of the ACC/AHA task force may
appear to be too complicated to use in routine care.
However, we have found that our two independent
investigators were able to apply the guidelines to
files stored in the database without major difficulty.
Furthermore, the conclusion drawn by each investi-
gator for each file was similar in all cases, suggesting
that most of the clinical situations met by physicians
during the preoperative evaluation of patients are
adequately covered. This algorithm is now routinely
used at our institution.
In conclusion, our findings demonstrate that the
ACC/AHA guidelines may prove effective in strati-
fying cardiac risk and identifying the patients at high
risk, by using clinical predictors and an estimate of
the physical capacity of the patient. This allows for a
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valuable reduction in the indications for noninvasive
testing, while permitting the selection of all patients
likely to benefit from preoperative CAD manage-
ment. The guidelines and their link to outcome
measurements in clinical studies need to be validat-
ed for other surgical procedures. 
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